Atlas market file · Equity · United States
Dow Inc.DOW
- Last close
- 30.3
- Change
- +2.12%
- 96-bar range
- 26.8 – 42.74
- As of
- 6 Aug 2026
Dow Inc. is a plastic materials, synth resins & nonvulcan elastomers issuer listed as DOW on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-43.40% over the window).
Source rail: Yahoo Finance chart API (DOW). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for DOW. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
DOW public profile
Plastic materials, synth resins & nonvulcan elastomers issuer. Dow Inc. is connected to current market context, cited company sources and its retained research file.
Dow Inc. trades as DOW on NYSE. Dow Inc. (DOW) has a latest verified close of 30.3, up 2.12%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files DOW under USA Stocks for browsing.
What changed for Dow Inc. today
Dow Inc. is a chemicals behemoth whose products still promise to untangle the world’s sticky problems-except, apparently, its own finances. The company’s latest 10-Q for the quarter ended 31 March 2026 shows revenues of $9.79 billion, but net income attributable to the parent was a loss of $533 million, or $-0.74 per diluted share. The filing’s dry language cannot mask the fact that the giant’s ethylene cracker in Alberta, touted as a carbon-neutral marvel, has yet to convert promise into profit. Meanwhile, the company’s cash pile stands at $4.11 billion, which sounds healthier than it feels when you’re losing half a billion each quarter.
In theory, Dow still sells chemicals: solvents, glycols, silicone release agents, and energy-focused products for oil, gas, and mining. Its product rails insist that 98 percent of revenue comes from product sales, a statistic that sounds sturdy until you realise that 98 percent of $9.79 billion still lost $533 million. The company’s inventory rose by $180 million in the quarter, suggesting someone in Midland, Freeport, or Alberta is betting on a demand rebound that hasn’t materialised. The diluted share count ticked up to 721.2 million, up from 715 million last year, because even the most optimistic polymer chemist can’t outrun dilution arithmetic.
The filing evidence is plain: revenues $9.79B, net loss attributable $-533M, diluted EPS $-0.74, operating cash flow $1.12B, inventory up $180M, diluted shares 721.2M. The company’s assets totalled $59.78B, with stockholders’ equity at $15.25B. The 10-Q also repeats cautionary language about the Alberta ethylene cracker and derivatives facility as a hoped-for driver of carbon-neutral chemistry, but the filing does not yet show that hope on the income statement. The 8-K filings around the common stock offering and shelf registration underscore management’s preference for keeping the capital stack flexible, even as the operating cash flow struggles to outpace the red ink.
The product rails themselves are real enough: solvents and glycols for formulation advantages, silicone release agents for food-contact and film applications, and energy-focused products for oil, gas, and mining operations. The company’s own pages explain how to manage and place orders, but the filings don’t explain how to turn losses into profits. The Alberta cracker’s promise remains a filing footnote, not an earnings driver.
For context, the company’s revenue remains 98 percent tied to product sales, per the 10-Q, but the scale of the loss shows that the company’s markets, cycles, and competing technologies are not yet cooperating. The board’s recent 8-K activity-common stock offering, shelf registration, and a corrected 8-K/A-reads like a polite game of corporate whack-a-mole rather than a coherent capital-return strategy. The operating cash flow of $1.12 billion is real, but it’s not enough to cover the quarterly loss. The inventory build of $180 million suggests management is betting on a rebound that hasn’t arrived. The Alberta cracker is cited as a key enabler of carbon-neutral chemistry, but the filings do not yet show it paying dividends. The company’s cash and cash equivalents stood at $4.11 billion, but the loss means that cash is being consumed faster than it’s being generated.
What remains unproven is whether the Alberta cracker can convert its promised carbon-neutral chemistry into profitable volumes, and whether management’s preference for keeping the capital stack flexible will translate into shareholder returns or merely more dilution. The evidence we have shows a chemicals giant still waiting for its operating model to catch up with the narrative. A credible inflection would require a sequential improvement in net income, a reduction in the cash burn rate, or hard evidence that the Alberta cracker is ramping cash-positive. Until then, the filings remain a polite corporate note offering to pay you back in 2029.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DOW technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DOW
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DOW research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DOW FAQ
What is Dow Inc. (DOW)?Dow Inc. (DOW) has a latest verified close of 30.3, up 2.12%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks...
Dow Inc. (DOW) has a latest verified close of 30.3, up 2.12%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DOW?Dow Inc. (DOW) has a latest verified close of 30.3, up 2.12%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the...
Dow Inc. (DOW) has a latest verified close of 30.3, up 2.12%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files DOW under USA Stocks for browsing.
How often is the DOW page updated?The DOW public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DOW public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DOW?The DOW file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DOW. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The DOW file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:DOW. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DOW?Yes. The workstation can open DOW, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DOW, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DOW page investment advice?No. The DOW page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DOW page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
DOW
Equity · evidence first